Suppr超能文献

一种从临床样本中对高变区 Plasmodium falciparum 基因 var2csa 进行测序的新方法。

A new method for sequencing the hypervariable Plasmodium falciparum gene var2csa from clinical samples.

机构信息

Division of Malaria Research, Institute for Global Health, University of Maryland School of Medicine, Baltimore, MD, USA.

Institute for Genome Sciences, University of Maryland School of Medicine, Baltimore, MD, USA.

出版信息

Malar J. 2017 Aug 17;16(1):343. doi: 10.1186/s12936-017-1976-8.

Abstract

BACKGROUND

VAR2CSA, a member of the Plasmodium falciparum erythrocyte membrane protein 1 (PfEMP1) family, mediates the binding of P. falciparum-infected erythrocytes to chondroitin sulfate A, a surface-associated molecule expressed in placental cells, and plays a central role in the pathogenesis of placental malaria. VAR2CSA is a target of naturally acquired immunity and, as such, is a leading vaccine candidate against placental malaria. This protein is very polymorphic and technically challenging to sequence. Published var2csa sequences, mostly limited to specific domains, have been generated through the sequencing of cloned PCR amplicons using capillary electrophoresis, a method that is both time consuming and costly, and that performs poorly when applied to clinical samples that are commonly polyclonal. A next-generation sequencing platform, Pacific Biosciences (PacBio), offers an alternative approach to overcome these issues.

METHODS

PCR primers were designed that target a 5 kb segment in the 5' end of var2csa and the resulting amplicons were sequenced using PacBio sequencing. The primers were optimized using two laboratory strains and were validated on DNA from 43 clinical samples, extracted from dried blood spots on filter paper or from cryopreserved P. falciparum-infected erythrocytes. Sequence reads were assembled using the SMRT-analysis ConsensusTools module.

RESULTS

Here, a PacBio sequencing-based approach for recovering a segment encoding the majority of VAR2CSA's extracellular region is described; this segment includes the totality of the first four domains in the 5' end of var2csa (~5 kb), from clinical malaria samples. The feasibility of the method is demonstrated, showing a high success rate from cryopreserved samples and more limited success from dried blood spots stored at room temperature, and characterized the genetic variation of the var2csa locus.

CONCLUSIONS

This method will facilitate a detailed analysis of var2csa genetic variation and can be adapted to sequence other hypervariable P. falciparum genes.

摘要

背景

VAR2CSA 是恶性疟原虫红细胞膜蛋白 1(PfEMP1)家族的成员,介导恶性疟原虫感染的红细胞与硫酸软骨素 A 的结合,硫酸软骨素 A 是胎盘细胞表面表达的一种分子,并在胎盘疟疾的发病机制中起核心作用。VAR2CSA 是天然免疫的靶标,因此是预防胎盘疟疾的主要候选疫苗。该蛋白具有高度多态性,测序技术上具有挑战性。已发表的 var2csa 序列主要局限于特定的结构域,是通过毛细管电泳对克隆 PCR 扩增子进行测序而获得的,这种方法既费时又昂贵,而且在应用于通常为多克隆的临床样本时效果不佳。一种新一代测序平台——太平洋生物科学公司(PacBio)提供了一种克服这些问题的替代方法。

方法

设计了针对 var2csa 5'端 5kb 片段的 PCR 引物,并用 PacBio 测序对扩增子进行测序。使用两个实验室菌株对引物进行了优化,并在从滤纸干血斑或冷冻保存的恶性疟原虫感染红细胞中提取的 43 份临床样本的 DNA 上进行了验证。使用 SMRT-analysis ConsensusTools 模块对序列进行组装。

结果

本文描述了一种基于 PacBio 测序的方法,用于恢复编码 VAR2CSA 大部分细胞外区的片段;该片段包括 var2csa 5'端前四个结构域的全部(~5kb),来自临床疟疾样本。该方法的可行性得到了证明,从冷冻保存的样本中获得了很高的成功率,而从室温储存的干血斑中获得的成功率有限,并对 var2csa 基因座的遗传变异进行了特征描述。

结论

该方法将促进 var2csa 遗传变异的详细分析,并可适应于其他高度可变的恶性疟原虫基因的测序。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/acd4/5561619/ad4ad317bbff/12936_2017_1976_Fig1_HTML.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验